Unvaccinated people develop much broader antibody immunity after being infected with COVID than people who have received the mRNA shots do, according to an NIH study. And the gap was large whether subjects had mild, moderate, or severe COVID infections.
The results of the study, which were highlighted by Alex Berenson on his Unreported Truths Substack, Daniel Horowitz at the Blaze, and Igor Chudov on his Substack newsletter, completely destroy the regime narrative that the shots provide stronger immunity than a natural infection, and may help explain why so many vaccinated Americans are now suffering from multiple COVID infections.
The pharmaceutical company Moderna on Friday recalled 764,900 doses of its Spikevax COVID-19 vaccine after a “foreign body” was found in a vial.
The contaminated lot was manufactured at a contract manufacturing site, ROVI, in Spain, and was distributed in mid-January 2022 in Norway, Poland, Portugal, Sweden and Spain, according to a company press release.
Moderna, the developer of one of the key COVID-19 vaccines, will open a new Enterprise Solutions Hub in Atlanta, according to a release from Governor Brian Kemp’s office.
The biotechnology company will create at least 150 new jobs over the next two years, as operations begin later this year.
The Centers for Disease Control and Prevention has updated the amount of time it recommends people isolate themselves after testing positive for COVID-19, shortening it from 10 days to five.
“Given what we currently know about COVID-19 and the Omicron variant, CDC is shortening the recommended time for isolation from 10 days for people with COVID-19 to 5 days, if asymptomatic, followed by 5 days of wearing a mask when around others,” the CDC said in a statement Monday.
The CDC changed the guidance because officials believe the data indicates the majority of COVID-19 transmission takes place early in the course of the illness, “generally in the 1-2 days prior to onset of symptoms and the 2-3 days after,” the statement said.
The Food and Drug Administration (FDA) approved Moderna and Pfizer’s COVID-19 vaccines for booster shot use for adults in the U.S., the agency announced Friday,
The announcement was made just two months after the FDA first rejected the White House’s plan to administer booster shots to all adults the week of Sept. 20. FDA Acting Commissioner Janet Woodcock approved the booster without holding the usual public meeting to review the data, and the Centers for Disease Control and Prevention (CDC) will meet Friday afternoon to discuss the authorization, according to the FDA press release.
“Throughout the course of the COVID-19 pandemic, the FDA has worked to make timely public health decisions as the pandemic evolves. COVID-19 vaccines have proven to be the best and highly effective defense against COVID-19,” Woodcock said in the press release.
On Friday, the San Francisco Chronicle published an article noting that California has some of the lowest COVID-19 case rates in the US, even though the Golden State’s vaccination rate lags many states that are currently struggling with the delta variant.
“One clear example is the New England states of Vermont and Maine,” the Chronicle reported. “Relatively shielded from the worst of the nation’s previous surges, they have struggled against the delta variant, which has sent their case rates soaring.”
On Friday, September 17, the CDC published a study that refutes the common claim that COVID-19 is a “pandemic of the unvaccinated.” Coauthored by more than 50 MD’s and Ph.D.’s, the study contains data on the vaccine status of adults hospitalized with COVID-19 (C-19) at 21 U.S. hospitals across 18 states during March to August of 2021.
Contrary to assertions from the Associated Press and Anthony Fauci that fully vaccinated people comprise only 1% of those being hospitalized or killed by C-19, the study found that 13% of patients hospitalized with C-19 had been fully vaccinated. Moreover, that 13% figure is just the tip of the iceberg because the authors excluded from their study a large group of hospitalized C-19 patients, the bulk of whom were likely vaccinated.
The Biden administration announced Wednesday that federal health experts now recommend vaccinated Americans receive a COVID booster shot.
The boosters will be widely distributed to the public after research indicated that the vaccine’s effectiveness declines over time.
Joe Biden is planning an effort to distribute doses of the Johnson & Johnson vaccine to illegal aliens pouring into the United States across the southern border, as reported by Breitbart.
The report first came from the Washington Post, after several officials with the Department of Homeland Security (DHS) spoke under condition of anonymity. According to the officials, federal authorities will soon begin administering the single-shot vaccine to illegals currently held in U.S. custody along the southern border with Mexico. DHS plans to get illegals vaccinated as soon as possible upon their entry into the country, to be done even before they are fully processed.
For the first time in months, not one state reported a dramatic weekly increase in coronavirus cases.
While average daily cases fell by less than 10% in 11 states, 37 states saw cases fall by over 10% and just two states had cases marginally increase, according to data from Johns Hopkins University. The United States also averaged fewer than 40,000 daily cases last week, a 21% drop from the week prior and the lowest total since September.
Death and hospitalization rates have also plummeted nationwide. The U.S. has averaged 600 deaths per day, the lowest point in approximately 10 months. If the number continues to fall the nation could soon hit its lowest point of the entire pandemic, according to the Associated Press.
The Pfizer and Moderna coronavirus vaccines are highly effective against and prevent illness from common variants of the virus, according to recently released studies.
The vaccine made by Pfizer is effective against the coronavirus variants that originated from the U.K. and South Africa, according to multiple studies released Wednesday that examined real-world vaccinations, The New York Times reported. Moderna reported that an early-stage trial suggested its vaccine is effective against the South African variant and a third variant originating from Brazil when given as a single-dose booster shot.
“At this point in time, we can confidently say that we can use this vaccine, even in the presence of circulating variants of concern,” London School of Hygiene and Tropical Medicine infectious disease researcher Annelies Wilder-Smith told the NYT.
Recent studies indicate that the Pfizer and Moderna coronavirus vaccines may have reduced protection against the South African coronavirus strain, according to reports in the New England Journal of Medicine, raising concerns that they could be less effective against future mutations.
Though both vaccines appeared to generate enough antibodies to neutralize the mutant strain, they both produced fewer antibodies when compared to the original virus. But experts warned that it was unclear just how much protection was needed to neutralize the variant, which scientists believe is more contagious than the original strain.
Few people realize that the Moderna vaccine against COVID-19—which the FDA has finally declared “highly effective,” and which is now being distributed to Americans—has actually been available for nearly a year.
But the government wouldn’t let you take it.
The two coronavirus vaccines that have been approved for emergency use authorization in the U.S. will be able to combat a new, more contagious strain of the virus in the U.K., experts said Monday.
Vaccines made by pharmaceutical companies Pfizer and Moderna will be effective against the new strain, which is “very similar” to previous strains at the genetic level, University of Washington’s Institute for Health Metrics and Evaluation affiliate assistant professor Vin Gupta told CNBC. The Food and Drug Administration has approved both vaccines for emergency use authorization after large-scale human trials showed efficacy of more than 90%.
The nurse who appeared to faint after receiving a COVID-19 vaccine in a viral video has recovered, according to a statement issued by her employer. Tiffany Dover, a nurse at CHI Memorial Hospital, reportedly came close to passing out due to a medical condition unrelated to the vaccination.
The hospital also cited information from the Centers for Disease Control (CDC) website, which stated that fainting sometimes occurs after all types of vaccinations.
The FDA approved Moderna’s coronavirus vaccine for emergency use Friday, making the United States the first country to have approved two safe and effective vaccines against COVID-19.
Its approval follows a key FDA panel’s overwhelming vote Thursday to endorse the vaccine’s safety and efficacy. The Moderna vaccine’s approval means that its distribution could begin within hours, providing hospitals and long-term care facilities across the country thousands of much-needed doses.
The FDA released data Tuesday reaffirming that Moderna’s coronavirus vaccine is safe and effective in preventing severe cases in adults.
The release is a sign that the vaccine is likely to be granted emergency use from the FDA in the coming days, public health officials said, a critical step in ensuring that millions of Americans can be vaccinated as soon as possible. The FDA released similar data regarding Pfizer’s vaccine just days before it was given emergency approval as well.
A total of 5,850 doses of vaccines arrived in Georgia Monday, as part of a “two-dose series.”
According to the Georgia Department of Public Health (DPH), “initial COVID-19 vaccine supply is limited, DPH is following the recommendations of the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP) and prioritizing healthcare personnel and residents of long-term care facilities for vaccination. Vaccine will be given through closed points of dispensing or PODs. These sites include public health clinics, hospitals, long-term care facilities, pharmacies, etc., and are only accessible to individuals in defined priority groups.”
Pharmaceutical company Moderna announced Monday that it will submit its coronavirus vaccine to the federal government for emergency use authorization approval.
Moderna said it would ask the Food and Drug Administration (FDA) for approval after its large-scale human trial concluded and showed the company’s vaccine to have an overall efficacy of 94.1%, according to NBC News. The vaccine was found to be 100% effective in preventing severe cases of coronavirus, according to Moderna.
Many states in the U.S. are hinging their COVID-19 mitigation strategies on the availability of a widely available vaccine. An issue bound to arise is the extremely cold temperatures the most promising experimental vaccines need to be kept at and the logistics of delivering them across the country.
Moderna’s COVID-19 vaccine is estimated to remain stable at standard refrigerator temperatures of 36° to 46°F for 30 days. Longer storage means a required temperature of mRNA-1273 needs -4°F for up to six months.